Nanobiotix SA, a clinical-stage biotechnology, is focused on the development of candidate products for the treatment of cancer. The company is headquartered in Paris, France. Show more

60 RUE DE WATTIGNIES, PARIS, FRANCE, 75012, Paris, 75012, USA

https://www.nanobiotix.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

2.008B

52 Wk Range

$6.97 - $57.14

Previous Close

$38.89

Open

$40.26

Volume

91,603

Day Range

$38.90 - $40.26

Enterprise Value

2.022B

Cash

52.75M

Avg Qtr Burn

-16.01M

Insider Ownership

0.00%

Institutional Own.

11.75%

Qtr Updated

12/31/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
NBTXR3 +/- Cetuximab Details Head and neck cancer	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
JNJ-1900 (NBTXR3) Details Non-small cell lung carcinoma, Cancer	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RT + NBTXR3 + Chemotherapy Details Esophageal cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RT + NBTXR3 Details Cancer, Pancreatic cancer	Phase 1b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RT + NBTXR3 Details Cancer, Non-small cell lung carcinoma	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
JNJ-1900 (NBTXR3) + Anti-PD-1 Details Head and neck cancer, Cancer, Non-small cell lung carcinoma, Solid tumor/s	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
JNJ-1900 (NBTXR3) Details Pancreatic Cancer	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.